GPIIb/IIIa inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GPIIb/IIIa inhibitor, covering 2023-04-04 to 2023-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients [Phase 2]